Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Capitol Hill In Brief

This article was originally published in The Gray Sheet

Executive Summary

House bill would let labs bill Medicare directly: Reps. Jason Altmire, D-Pa., Anna Eshoo, D-Calif., and Tim Murphy, R-Pa., introduced the "Patient Access to Critical Lab Tests Act" (H.R. 1699) March 25 to allow independent clinical laboratories to directly bill Medicare Part B for complex diagnostics - instead of relying on the treating hospital as an intermediary. The bill, which is supported by the American Clinical Laboratory Association, will allow independent labs offering genetic and molecular tests and other personalized medicine diagnostics to bypass current Medicare rules requiring hospitals to pay laboratories for the tests and later bill Medicare for reimbursement. "Unfortunately, today's arcane Medicare billing regulations often discourage hospitals from ordering these potentially life-saving tests for their patients," Altmire said. A companion bill has yet to be introduced in the Senate

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027255

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel